Kinter A, Catanzaro A, Monaco J, Ruiz M, Justement J, Moir S, Arthos J, Oliva A, Ehler L, Mizell S, Jackson R, Ostrowski M, Hoxie J, Offord R, Fauci A S
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11880-5. doi: 10.1073/pnas.95.20.11880.
This study demonstrates that several CC-chemokines, including those that inhibit entry and replication of macrophage-tropic strains of HIV, increase the replication of T cell (T)-tropic strains in CD4(+) T cells. Enhancement of T-tropic HIV replication is observed at early stages of replication, requires signaling through inhibitory guanine nucleotide-binding regulatory (Gi) proteins, and is associated with increased cell surface colocalization of CD4 and the T-tropic HIV coreceptor CXCR4. These findings may further our understanding of the factors that influence the replication and spread of T-tropic strains of HIV in vivo and suggest that the use of cell signaling CC-chemokines as therapeutic agents for the purpose of limiting HIV replication in vivo should be approached with caution.
本研究表明,几种CC趋化因子,包括那些抑制HIV巨噬细胞嗜性毒株进入和复制的趋化因子,可增加CD4(+)T细胞中T细胞嗜性毒株的复制。在复制早期即可观察到T嗜性HIV复制增强,这需要通过抑制性鸟嘌呤核苷酸结合调节(Gi)蛋白进行信号传导,并且与CD4和T嗜性HIV共受体CXCR4在细胞表面的共定位增加有关。这些发现可能会加深我们对影响HIV T嗜性毒株在体内复制和传播因素的理解,并表明将细胞信号CC趋化因子用作体内限制HIV复制的治疗药物时应谨慎行事。